Caxton Associates (New York)’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-17,600
Closed -$1.91M 424
2018
Q2
$1.91M Buy
17,600
+12,400
+238% +$1.33M 0.1% 129
2018
Q1
$541K Buy
+5,200
New +$605K 0.03% 251
2014
Q4
Sell
-40,000
Closed -$3.1M 129
2014
Q3
$3.1M Buy
+40,000
New +$3.09M 0.1% 125
2013
Q4
Sell
-81,438
Closed -$6.18M 226
2013
Q3
$6.18M Sell
81,438
-23,562
-22% -$1.72M 0.32% 70
2013
Q2
$7.78M Buy
+105,000
New +$7.04M 0.39% 51

Other funds holding CRI

Caxton Associates (New York)'s CRI Position: Q3 2018 in Review

Caxton Associates (New York) sold out of Carter's (CRI) in Q3 2018, closing a stake of 17,600 shares — an estimated $1.91M sold.

Caxton Associates (New York) first reported a position in CRI in Q2 2013 and held it in 5 quarters. The position peaked at $7.78M in Q2 2013. 332 funds tracked by Wall St. Rank hold CRI as of Q3 2018.

  • Caxton Associates (New York) reported no remaining Carter's position as of Q3 2018 after selling out during the quarter.
  • Caxton Associates (New York) sold 17,600 Carter's shares in Q3 2018, an estimated $1.91M.
  • Caxton Associates (New York) first reported a position in Carter's in Q2 2013 and held it in 5 quarters.
  • Caxton Associates (New York)'s Carter's position peaked at $7.78M in Q2 2013.
  • 332 funds tracked by Wall St. Rank held Carter's as of Q3 2018.

Based on Caxton Associates (New York)'s 13F filing for Q3 2018, filed 14 Nov 2018.